Founded in 2018, Causaly has the mission to “redefine the boundaries of human discovery by harnessing transformative AI technologies”. Their unique AI platform provides a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed, and applied in critical decision-making processes in drug discovery and development.
Causaly helps pharmaceutical leaders, consumer goods manufacturers, life science investors and others to accelerate scientific discovery and research. With large established pharmaceutical companies as key clients, it is essential that Causaly is able to provide assurance of it’s information security. At the end of 2022, the new VP of Engineering reached out to Freeman Clarke for an expert to help them through process of re-certifying their ISO27001 accreditation. Chris Hewertson, one of the experienced team of fractional CIOs, ran a complementary risk management workshop and was then appointed as an information security advisor.
Chris worked with Causaly to review the full scope of ISO requirements and prioritize improvements in processes, tools and suppliers in order deliver demonstrable improvements in overall security.
Andrew Taylor, VP of Engineering commented:
“I can’t recommend Freeman Clarke highly enough. From initial contact it took only days to have a highly experienced advisor supporting us. It was great to have someone who has been there, seen it, and knows not only the pitfalls to avoid, but also how to take a pragmatic approach to speeding things up.”
Plain English board-level briefings focused on technology strategies to deliver competitive advantage and business success.
You can unsubscribe at any time.
Call us on 0203 020 1864 with any questions.
Graeme Freeman
Co-Founder and Director
Plain English board-level briefings focused on technology strategies to deliver competitive advantage and business success.
You can unsubscribe at any time.
Call us on 0203 020 1864 with any questions.